Connecting top research institutions, biotech companies, and innovation hubs for collaborative synthetic biology breakthroughs.
Our technology network connects over 150 leading institutions to accelerate innovation through shared resources, collaborative R&D, and cross-industry partnerships.
Over 30+ institutions across 12 countries in our network facilitating international research partnerships.
Joint access to over $3B in shared lab facilities, sequencing services, and computational biotech tools.
IP-sharing agreements and joint development frameworks that foster rapid technology commercialization.
Our partners span across 20+ countries driving global synthetic biology advancement
Member Institutions
Countries Represented
Joint Research Projects
Commercialized Technologies
Institutions and biotech companies driving innovation together
Our structured collaboration framework enables seamless innovation across the network
Researchers identify high-impact targets through network-wide innovation forums and pre-competitive R&D meetings.
Matching projects with appropriate infrastructure, expertise and funding from network members through collaborative planning.
Cross-institution teams work together on specific research and development tasks with shared data and IP frameworks.
Streamlined pathways for bringing innovations to market through joint venture models, licensing and open-source platforms.
75% of network innovations reach commercialization within 36 months.
Become part of the largest collaborative synthetic biology network in the world.
Our membership program includes academic institutions, corporate partners and startups. We offer different tiers of engagement including research collaboration, infrastructure access, and co-development opportunities.